Rising US-Iran tensions and surging AI-driven electricity demand are creating a volatile two-front energy crisis for investors.
Moonshot AI's Kimi K3 launch proves that affordable models fuel demand for HBM chips and hardware infrastructure, benefiting semiconductor leaders.
Biotech is seeing a resurgence in 2026 as big pharma firms acquire new assets to counter looming patent cliffs, fueling a strong market for new IPOs.
Record defense spending is flowing largely to legacy contractors, challenging the narrative of a startup-led military innovation boom.
The film industry sees a strong recovery as The Odyssey hits global box office targets and theater chains post record revenue growth.
